Similar articles

• Some behavioural and EEG studies on the behavioural depression induced in the rat by ethanolamine O-sulphate, an inhibitor of GABA-transaminase [proceedings].

  Baxter MG, Leach MJ, Miller AA, Sethna DM, Wheatley PL. Baxter MG, et al. Br J Pharmacol. 1976 Jul;57(3):431P-432P. Br J Pharmacol. 1976. PMID: 974330 Free PMC article. No abstract available.
• The involvement of 5-hydroxytryptamine and dopamine in the behavioural effects of alpha-methyltryptamine [proceedings].

  Marsden CA. Marsden CA. Br J Pharmacol. 1978 Nov;64(3):431P. Br J Pharmacol. 1978. PMID: 719281 Free PMC article. No abstract available.
• Behavioural changes following olfactory bulbectomy in rats: a possible model for the detection of antidepressant drugs [proceedings].

  van Riezen H, Schnieden H, Wren A. van Riezen H, et al. Br J Pharmacol. 1976 Jul;57(3):426P-427P. Br J Pharmacol. 1976. PMID: 974328 Free PMC article. No abstract available.
• Effect of a potent synthetic opioid pentapeptide in some anti-nociceptive and behavioural tests in mice and rats [proceedings].

  Baxter MG, Goff D, Miller AA, Saunders IA. Baxter MG, et al. Br J Pharmacol. 1977 Mar;59(3):455P-456P. Br J Pharmacol. 1977. PMID: 843701 Free PMC article. No abstract available.
• Relevance of the enhanced 5-hydroxytryptamine behavioural responses in rats to electroconvulsive therapy [proceedings].

  Costain DW, Grahame-Smith DG, Green AR. Costain DW, et al. Br J Pharmacol. 1978 Mar;62(3):394P. Br J Pharmacol. 1978. PMID: 638326 Free PMC article. No abstract available.